Based in China, Brise Pharma is a startup founded in 2018. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Brise Pharma is a clinical-stage biopharmaceutical company focused on developing innovative and highly differentiated treatments for severe pain conditions, including migraine, inflammatory pain, and neuropathic pain.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.